Cargando…
Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by hamartomas in the skin and other organs, including brain, heart, lung, kidney and bones. TSC is caused by mutations in TSC1 and TSC2. Here, we present the TSC1 and TSC2 variants identified in 168 Danish individuals o...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303179/ https://www.ncbi.nlm.nih.gov/pubmed/32555378 http://dx.doi.org/10.1038/s41598-020-66588-4 |
_version_ | 1783547995728379904 |
---|---|
author | Rosengren, Thomas Nanhoe, Santoesha de Almeida, Luis Gustavo Dufner Schönewolf-Greulich, Bitten Larsen, Lasse Jonsgaard Hey, Caroline Amalie Brunbjerg Dunø, Morten Ek, Jakob Risom, Lotte Nellist, Mark Møller, Lisbeth Birk |
author_facet | Rosengren, Thomas Nanhoe, Santoesha de Almeida, Luis Gustavo Dufner Schönewolf-Greulich, Bitten Larsen, Lasse Jonsgaard Hey, Caroline Amalie Brunbjerg Dunø, Morten Ek, Jakob Risom, Lotte Nellist, Mark Møller, Lisbeth Birk |
author_sort | Rosengren, Thomas |
collection | PubMed |
description | Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by hamartomas in the skin and other organs, including brain, heart, lung, kidney and bones. TSC is caused by mutations in TSC1 and TSC2. Here, we present the TSC1 and TSC2 variants identified in 168 Danish individuals out of a cohort of 327 individuals suspected of TSC. A total of 137 predicted pathogenic or likely pathogenic variants were identified: 33 different TSC1 variants in 42 patients, and 104 different TSC2 variants in 126 patients. In 40 cases (24%), the identified predicted pathogenic variant had not been described previously. In total, 33 novel variants in TSC2 and 7 novel variants in TSC1 were identified. To assist in the classification of 11 TSC2 variants, we investigated the effects of these variants in an in vitro functional assay. Based on the functional results, as well as population and genetic data, we classified 8 variants as likely to be pathogenic and 3 as likely to be benign. |
format | Online Article Text |
id | pubmed-7303179 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-73031792020-06-22 Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex Rosengren, Thomas Nanhoe, Santoesha de Almeida, Luis Gustavo Dufner Schönewolf-Greulich, Bitten Larsen, Lasse Jonsgaard Hey, Caroline Amalie Brunbjerg Dunø, Morten Ek, Jakob Risom, Lotte Nellist, Mark Møller, Lisbeth Birk Sci Rep Article Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by hamartomas in the skin and other organs, including brain, heart, lung, kidney and bones. TSC is caused by mutations in TSC1 and TSC2. Here, we present the TSC1 and TSC2 variants identified in 168 Danish individuals out of a cohort of 327 individuals suspected of TSC. A total of 137 predicted pathogenic or likely pathogenic variants were identified: 33 different TSC1 variants in 42 patients, and 104 different TSC2 variants in 126 patients. In 40 cases (24%), the identified predicted pathogenic variant had not been described previously. In total, 33 novel variants in TSC2 and 7 novel variants in TSC1 were identified. To assist in the classification of 11 TSC2 variants, we investigated the effects of these variants in an in vitro functional assay. Based on the functional results, as well as population and genetic data, we classified 8 variants as likely to be pathogenic and 3 as likely to be benign. Nature Publishing Group UK 2020-06-18 /pmc/articles/PMC7303179/ /pubmed/32555378 http://dx.doi.org/10.1038/s41598-020-66588-4 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Rosengren, Thomas Nanhoe, Santoesha de Almeida, Luis Gustavo Dufner Schönewolf-Greulich, Bitten Larsen, Lasse Jonsgaard Hey, Caroline Amalie Brunbjerg Dunø, Morten Ek, Jakob Risom, Lotte Nellist, Mark Møller, Lisbeth Birk Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex |
title | Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex |
title_full | Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex |
title_fullStr | Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex |
title_full_unstemmed | Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex |
title_short | Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex |
title_sort | mutational analysis of tsc1 and tsc2 in danish patients with tuberous sclerosis complex |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303179/ https://www.ncbi.nlm.nih.gov/pubmed/32555378 http://dx.doi.org/10.1038/s41598-020-66588-4 |
work_keys_str_mv | AT rosengrenthomas mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex AT nanhoesantoesha mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex AT dealmeidaluisgustavodufner mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex AT schonewolfgreulichbitten mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex AT larsenlassejonsgaard mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex AT heycarolineamaliebrunbjerg mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex AT dunømorten mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex AT ekjakob mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex AT risomlotte mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex AT nellistmark mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex AT møllerlisbethbirk mutationalanalysisoftsc1andtsc2indanishpatientswithtuberoussclerosiscomplex |